NLS Pharmaceutics Ltd (NLSP)

1.920 -0.46 (-19.33%) USD  |  NASDAQ  |  Dec 20, 16:00
1.95 +0.03 (+1.57%) After-Hours: 20:00
More

NLS Pharmaceutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for NLSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Ratios (EV) Definition

View Enterprise Value Ratios (EV) Definition
Start Trial

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
AC Immune SA Upgrade
CRISPR Therapeutics AG Upgrade
Addex Therapeutics Ltd Upgrade
Molecular Partners AG Upgrade
MoonLake Immunotherapeutics --

EV to Assets (Quarterly) Related Metrics

EV to Free Cash Flow Upgrade